The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.
Other Gold winners were Alliance Pharma, Bayer, CALM, Haleon, Kite Pharma, a Gilead Company, Kyowa Kirin, LEO Pharma, the RCN Foundation, Novartis, Santen, Takeda UK and UCB.
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending UCB's Bimzelx (bimekizumab), with the inflammatory disease drug now authorised by the institute to treat ... Claire Brading, managing director UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted UCB's Bimzelx (bimekizumab) two new approvals, with the inflammatory disease drug now authorised to treat certain adults with psoriatic arthritis ... Claire Brading, managing
by Ogilvy Health UK for UCB. People living with rare neuromuscular condition, myasthenia gravis (MG) liken themselves to ‘snowflakes’. ... Rare Disease Connect in Neurology: Cultivating a Global Learning Community - by Ogilvy Health UK for UCB.
Sponsored by. by Portland Communications. for Industry Dermatology Initiative (At the time of event delivery, IDI membership comprised of AbbVie, Almirall, Eli Lilly &Company, LEO Pharma, Novartis and UCB). ... for Industry Dermatology Initiative (At the
No results were found
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...